Physician profile
Hammad Aziz
NPI 1154505253
$10,349.15
in general payments reported to CMS, 2019-2025
39 companies · $2,112 in 2025
The $2,112 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,476 · 2020: $274 · 2021: $250 · 2022: $1,325 · 2023: $2,741 · 2024: $2,172 · 2025: $2,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,024.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,615.25 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Watchman Access System |
| Amgen INC. | $1,035.24 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $683.59 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $676.89 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $545.67 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $494.14 | 2019-2025 | Lifevest |
| Abiomed | $472.15 | 2022-2025 | Impella |
| Novo Nordisk INC | $441.00 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $395.36 | 2021-2025 | Verquvo, Capvaxive |
| Abbott Laboratories | $378.30 | 2023-2025 | Triclip, Absolute Pro, Diamondback Peripheral |
| Astrazeneca Pharmaceuticals Lp | $363.54 | 2019-2025 | Farxiga, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $308.53 | 2019-2025 | Eliquis, Camzyos |
| Medtronic, INC. | $275.31 | 2021-2025 | Ffrangio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.10 | 2022-2025 | Jardiance |
| Penumbra, INC. | $169.01 | 2025 | Indigo System |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $139.10 | 2023-2024 | Inpefa |
| Philips North America LLC | $124.40 | 2024-2025 | Ecc Solutions, (Ck4) Mcot, Extended Holter |
| Zoll Circulation INC | $110.05 | 2023 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Esperion Therapeutics, INC. | $95.81 | 2022-2025 | Nexletol |
| Irhythm Technologies, INC. | $92.61 | 2024 | Zio Monitor, Zio Xt Patch |
| Actelion Pharmaceuticals US, INC. | $88.94 | 2024-2025 | Uptravi, Opsumit |
| Sanofi-Aventis U.S. LLC | $72.49 | 2019-2024 | |
| Shockwave Medical, INC | $65.55 | 2022-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Alnylam Pharmaceuticals INC. | $56.21 | 2019-2024 | Onpattro |
| Amarin Pharma, INC. | $55.58 | 2019-2020 | |
| Lundbeck LLC | $44.92 | 2019-2020 | |
| Scpharmaceuticals INC. | $43.41 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $42.89 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $40.51 | 2019 | |
| Arbor Pharmaceuticals, INC. | $35.90 | 2020 | |
| Stryker Corporation | $30.14 | 2025 | Flowtriever |
| Azurity Pharmaceuticals, INC. | $23.13 | 2023 | Edarbi |
| Glaxosmithkline, LLC. | $22.95 | 2025 | Shingrix, Arexvy |
| Cardiva Medical, INC. | $19.96 | 2025 | Optowire |
| Edwards Lifesciences Corporation | $19.60 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.88 | 2023 | |
| Heartflow, INC. | $16.79 | 2023 | Ffrct |
| Medtronic Vascular, INC. | $13.05 | 2020 | |
| Tactile Systems Technology INC | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hammad Aziz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.